Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07459829) titled 'Study of CU06-1004 in Patients With Daibetic Macular Edema' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Curacle Co., Ltd.

Condition: DME Diabetic Macular Edema Diabetic Macular Edema (DME)

Intervention: Drug: CU06-1004

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: December 1, 2026

Target Sample Size: 156

To know more, visit https://clinicaltrials.gov/study/NCT07459829

Publi...